Osborne Clarke LLP

Osborne Clarke LLP‘s patent group works under the leadership of experienced litigator Arty Rajendra, routinely acting for clients in innovation-driven sectors in contentious and non-contentious respects, including running biosimilars litigation, life sciences product launch strategies, SEP and FRAND disputes, IP-rich transactions, licensing matters, and more. Will James advises on strategy and acts for tech-driven companies, such as those in the medical devices, electronics, and life sciences spaces, in disputes. Tim Harris is engaged in a wide range of pharma, biotech, and life sciences litigation, and Trevor Crosse specialises in biopharmaceutical patent and SPC litigation, and helps clients to enforce and commercialise their rights.